false 2024-09-30 12-31 GH Research PLC 0001855129 0 0 0 0 1 0001855129 2024-01-01 2024-09-30 0001855129 2023-07-01 2023-09-30 0001855129 2023-01-01 2023-09-30 0001855129 2024-07-01 2024-09-30 0001855129 2024-09-30 0001855129 2023-12-31 0001855129 ifrs-full:OtherReservesMember 2023-12-31 0001855129 2022-12-31 0001855129 ifrs-full:AdditionalPaidinCapitalMember 2023-12-31 0001855129 ifrs-full:RetainedEarningsMember 2022-12-31 0001855129 ifrs-full:IssuedCapitalMember 2022-12-31 0001855129 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001855129 ifrs-full:RetainedEarningsMember 2023-12-31 0001855129 ifrs-full:OtherReservesMember 2022-12-31 0001855129 ifrs-full:AdditionalPaidinCapitalMember 2022-12-31 0001855129 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001855129 ifrs-full:IssuedCapitalMember 2023-12-31 0001855129 ifrs-full:AdditionalPaidinCapitalMember 2024-01-01 2024-09-30 0001855129 ifrs-full:AdditionalPaidinCapitalMember 2023-01-01 2023-09-30 0001855129 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-09-30 0001855129 ifrs-full:IssuedCapitalMember 2023-01-01 2023-09-30 0001855129 ifrs-full:RetainedEarningsMember 2024-01-01 2024-09-30 0001855129 ifrs-full:OtherReservesMember 2024-01-01 2024-09-30 0001855129 ifrs-full:OtherReservesMember 2023-01-01 2023-09-30 0001855129 ifrs-full:IssuedCapitalMember 2024-01-01 2024-09-30 0001855129 ifrs-full:RetainedEarningsMember 2023-01-01 2023-09-30 0001855129 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-09-30 0001855129 ifrs-full:OtherReservesMember 2023-09-30 0001855129 ifrs-full:OtherReservesMember 2024-09-30 0001855129 ifrs-full:IssuedCapitalMember 2024-09-30 0001855129 2023-09-30 0001855129 ifrs-full:AdditionalPaidinCapitalMember 2024-09-30 0001855129 ifrs-full:RetainedEarningsMember 2023-09-30 0001855129 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-09-30 0001855129 ifrs-full:AdditionalPaidinCapitalMember 2023-09-30 0001855129 ifrs-full:IssuedCapitalMember 2023-09-30 0001855129 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-09-30 0001855129 ifrs-full:RetainedEarningsMember 2024-09-30 0001855129 ghrs:FairValueThroughOtherComprehensiveIncomeMember 2023-12-31 0001855129 ghrs:FairValueThroughOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0001855129 ghrs:FairValueThroughOtherComprehensiveIncomeMember 2024-09-30 0001855129 2023-01-01 2023-12-31 0001855129 ifrs-full:TopOfRangeMember 2024-01-01 2024-09-30 0001855129 ifrs-full:BottomOfRangeMember 2024-01-01 2024-09-30 0001855129 2021-06-30 0001855129 ghrs:EmployeesMember 2024-07-01 2024-09-30 0001855129 ghrs:BoardOfDirectorsMember 2024-01-01 2024-09-30 0001855129 ghrs:BoardOfDirectorsMember 2024-07-01 2024-09-30 0001855129 ghrs:EmployeesMember 2024-01-01 2024-09-30 0001855129 ifrs-full:BottomOfRangeMember 2024-07-01 2024-09-30 0001855129 ifrs-full:TopOfRangeMember 2024-07-01 2024-09-30 0001855129 ghrs:NonExecutiveDirectorsMember 2024-01-01 2024-09-30 0001855129 ghrs:NonExecutiveDirectorsMember 2024-07-01 2024-09-30 0001855129 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-09-30 0001855129 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:pure ghrs:Segment xbrli:shares utr:Y

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2024.
Commission File Number: 001-40530
GH Research PLC
(Exact name of registrant as specified in its charter)
Joshua Dawson House
Dawson Street
Dublin 2
D02 RY95
Ireland
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F | ☒ |  | Form 40-F | ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On November 14, 2024, GH Research PLC (the “Company”) reported its third quarter 2024 financial results, provided business updates, and made available an updated investor presentation on its website. A copy of the press release is exhibited hereto as Exhibit 99.3 and a copy of the investor presentation is attached hereto as Exhibit 99.4.
The fact that this press release and investor presentation is being made available and furnished herewith should not be deemed an admission as to the materiality of any information contained in the materials. The information contained in the press release and investor presentation is being provided as of November 14, 2024, and the Company does not undertake any obligation to update the presentation in the future or to update forward-looking statements to reflect subsequent actual results.
1

INCORPORATION BY REFERENCE
This Report on Form 6-K (other than Exhibit 99.3 and Exhibit 99.4 hereto), including Exhibit 99.1 and Exhibit 99.2 hereto, shall be deemed to be incorporated by reference into the registration statement on Form S-8 (Registration No. 333-270422) and the registration statement on Form F-3 (Registration No. 333-270418) of the Company and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
2

EXHIBIT INDEX

Exhibit No. | Description
99.1 | Unaudited Condensed Consolidated Interim Financial Statements for the three and nine months ended September 30, 2024
99.2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations
99.3 | Press release dated November 14, 2024
99.4 | Corporate Presentation for November 2024
101.INS | Inline XBRL Instance Document
101.SCH | Inline XBRL Taxonomy Extension Schema Document
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document)

3

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| GH Research PLC
Date: November 14, 2024 |
| By: | /s/ Julie Ryan
| Name: | Julie Ryan
| Title: | Vice President, Finance

4